4 ms·

Could ibuprofen be an anti-aging medicine?

8 points by ca98am79 12y ago

lsaferite 12y ago
Well, it also unfortunately damages the liver. I know this because the military would hand out bottles of 1g pills like candy for every possible ailment you came to them with.
- jeffnv 12y ago
  Kidneys too.
- huxley 12y ago
  I AM NOT A DOCTOR OR PHARMACIST, but liver damage is more often caused by acetaminophen, it is quite rare with ibuprofen which tends to be associated with gastrointestinal bleeding or in extreme cases kidney damage (however ibuprofen is not as likely as other NSAIDs like Naproxen to cause kidney damage or failure) http://en.wikipedia.org/wiki/Ibuprofen#Adverse_effects http://en.wikipedia.org/wiki/Ibuprofen#Adverse_effects Update: 1G pills mentioned by parent may be children's dosage of acetaminophen http://www.drugs.com/imprints/1g-17321.html http://www.drugs.com/imprints/1g-17321.html
  - lsaferite 12y ago
    No, I'm sure they were Ibuprofen.
reasonattlm 12y ago
Paper: http://dx.doi.org/10.1371/journal.pgen.1004860 http://dx.doi.org/10.1371/journal.pgen.1004860 Every few years a new hot thing emerges in the field of drug candidates to slow aging. It was sirtuins for a while and then rapamycin and there will be others in due course. This happens because it is very possible to raise funding, start a company, and make a lot of money from this sort of thing even if - as is always the case to date - nothing of significance ever comes of it in terms of treatments that can actually extend life. As I've said in the past, this all seems like a really great cover story for the real scientific goal of amassing detailed data on the operation of cellular metabolism. The stated goals of slowing aging serve to draw in investment that would otherwise be hard to find at the needed levels: metabolism is ferociously complex, and trying to map it is chewing up billions of dollars. This is work that should be done, and the faster the better, but I think it disingenuous to talk of any real possibility that significant human life extension can result from it in the next few decades. For real progress in treating aging an entirely different direction in scientific strategy is needed. Not mining the natural world for drug candidates that might slow down aging in poorly understood ways by altering poorly understood metabolic mechanisms, but rather deliberately aimed efforts to repair the known and comparatively well understood forms of damage that cause aging. We can bypass the need for a full and detailed understanding of how this damage interacts with every part of our metabolism to cause aging by taking the well validated and time-proven list of fundamental differences between old tissue and young tissue - a list of forms of cellular and molecular damage - and then repairing those differences. There is even a detailed set of research plans leading to treatments that can achieve this goal, which is a very large departure from the world of slowing aging through metabolic manipulation, where there is no plan to speak of and nowhere near enough knowledge to create one. This is not even to mention the fact that slowing down damage accumulation can never be as good as repairing damage in terms of benefits delivered, and slowing further damage can do very little for old people who are already very damaged. The old need repair, and repair as a strategy is simply better overall in any case. It continues to amaze me that the clearly far worse, far more expensive, far less understood approach to treating aging is the one that dominates in this small research community. In any case, every time a new overhyped drug candidate to slow aging emerges people get excited about it. Short memories, if you ask me. But the next time that someone you know in the community becomes fired up about early stage development of an age-slowing drug candidate that extends life in animal studies you can offer some needed perspective by saying "but so does ibuprofen." And what does ibuprofen do for life span in humans? Nothing meaningful enough to show up in five decades of trials, studies, and worldwide usage. The goal of taking decades and billions to add just a few years to adult life expectancy doesn't fill me with glee. If that much time and money are to be expended, and I am to become old waiting, I want far better expected outcomes for success: decades of healthy life and rejuvenation, not pills to very slightly slow down the remaining decline. Fund research into repair biotechnologies after the SENS model, not the same old drug development programs that gave us a better knowledge of sirtuins and little else.
davidgerard 12y ago
Kurzweil's anti-aging medication thing has long ago taken a left-turn straight into pseudoscience. He has a thriving sideline selling unproven supplements as well. If he hits anything with evidence to it, it's by accident. To be fair, he appears to completely believe what he's pushing. But that doesn't make it any less pseudoscience.

8 points by ca98am79 12y ago

Well, it also unfortunately damages the liver. I know this because the military would hand out bottles of 1g pills like candy for every possible ailment you came to them with.

jeffnv 12y ago
Kidneys too.
huxley 12y ago
I AM NOT A DOCTOR OR PHARMACIST, but liver damage is more often caused by acetaminophen, it is quite rare with ibuprofen which tends to be associated with gastrointestinal bleeding or in extreme cases kidney damage (however ibuprofen is not as likely as other NSAIDs like Naproxen to cause kidney damage or failure) http://en.wikipedia.org/wiki/Ibuprofen#Adverse_effects http://en.wikipedia.org/wiki/Ibuprofen#Adverse_effects Update: 1G pills mentioned by parent may be children's dosage of acetaminophen http://www.drugs.com/imprints/1g-17321.html http://www.drugs.com/imprints/1g-17321.html
- lsaferite 12y ago
  No, I'm sure they were Ibuprofen.

reasonattlm 12y ago

Paper: http://dx.doi.org/10.1371/journal.pgen.1004860 http://dx.doi.org/10.1371/journal.pgen.1004860 Every few years a new hot thing emerges in the field of drug candidates to slow aging. It was sirtuins for a while and then rapamycin and there will be others in due course. This happens because it is very possible to raise funding, start a company, and make a lot of money from this sort of thing even if - as is always the case to date - nothing of significance ever comes of it in terms of treatments that can actually extend life. As I've said in the past, this all seems like a really great cover story for the real scientific goal of amassing detailed data on the operation of cellular metabolism. The stated goals of slowing aging serve to draw in investment that would otherwise be hard to find at the needed levels: metabolism is ferociously complex, and trying to map it is chewing up billions of dollars. This is work that should be done, and the faster the better, but I think it disingenuous to talk of any real possibility that significant human life extension can result from it in the next few decades. For real progress in treating aging an entirely different direction in scientific strategy is needed. Not mining the natural world for drug candidates that might slow down aging in poorly understood ways by altering poorly understood metabolic mechanisms, but rather deliberately aimed efforts to repair the known and comparatively well understood forms of damage that cause aging. We can bypass the need for a full and detailed understanding of how this damage interacts with every part of our metabolism to cause aging by taking the well validated and time-proven list of fundamental differences between old tissue and young tissue - a list of forms of cellular and molecular damage - and then repairing those differences. There is even a detailed set of research plans leading to treatments that can achieve this goal, which is a very large departure from the world of slowing aging through metabolic manipulation, where there is no plan to speak of and nowhere near enough knowledge to create one. This is not even to mention the fact that slowing down damage accumulation can never be as good as repairing damage in terms of benefits delivered, and slowing further damage can do very little for old people who are already very damaged. The old need repair, and repair as a strategy is simply better overall in any case. It continues to amaze me that the clearly far worse, far more expensive, far less understood approach to treating aging is the one that dominates in this small research community. In any case, every time a new overhyped drug candidate to slow aging emerges people get excited about it. Short memories, if you ask me. But the next time that someone you know in the community becomes fired up about early stage development of an age-slowing drug candidate that extends life in animal studies you can offer some needed perspective by saying "but so does ibuprofen." And what does ibuprofen do for life span in humans? Nothing meaningful enough to show up in five decades of trials, studies, and worldwide usage. The goal of taking decades and billions to add just a few years to adult life expectancy doesn't fill me with glee. If that much time and money are to be expended, and I am to become old waiting, I want far better expected outcomes for success: decades of healthy life and rejuvenation, not pills to very slightly slow down the remaining decline. Fund research into repair biotechnologies after the SENS model, not the same old drug development programs that gave us a better knowledge of sirtuins and little else.

davidgerard 12y ago

Kurzweil's anti-aging medication thing has long ago taken a left-turn straight into pseudoscience. He has a thriving sideline selling unproven supplements as well. If he hits anything with evidence to it, it's by accident. To be fair, he appears to completely believe what he's pushing. But that doesn't make it any less pseudoscience.